Latest News about Origin Therapeutics
Recent news which mentions Origin Therapeutics
Origin Therapeutics Attaches Clairvoyant To Its Portfolio, Fueling Fast Market Strategy For Psilocybin Therapy
July 07, 2022
From Benzinga
New Psychedelic Investment Opportunity: Look For "ORIG" (Origin Therapeutics) On The CSE Starting June 6
June 02, 2022
From Benzinga
Psyched: Atai Launches 'Salvia Divinorum' Subsidiary, Mindset, Psilera and Wesana's Preclinical Trials, Origin Raises $5M
August 16, 2021
From Benzinga
Origin Therapeutics Will Invest $6.5M In Psychedelics Startups
August 13, 2021
From Benzinga